Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument

K-Number: K232027 · 2024-04-04

ApplicantSebia
Decision Date2024-04-04
Product CodeGKA
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument is a medical device manufactured by Sebia. It received FDA 510(k) clearance on 2024-04-04 under approval number K232027. The device is classified under product code GKA. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument?

CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument is a medical device that received FDA 510(k) clearance on 2024-04-04. It is manufactured by Sebia. The 510(k) number is K232027.

When was CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument approved by the FDA?

CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument received FDA 510(k) clearance on 2024-04-04, under approval number K232027.

What company makes CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument?

CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument is manufactured by Sebia.

What is the FDA product code for CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument?

The FDA product code for CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument is GKA.

Other Devices by Sebia

View all 12 devices →

Related Devices (Code: GKA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.